Figure 2.

Kaplan-Meier estimations of the probability (with 95% confidence intervals) to be free of adverse events after initiating a first-line antiretroviral therapy.

Prosperi et al. BMC Infectious Diseases 2012 12:296   doi:10.1186/1471-2334-12-296
Download authors' original image